Cingulate Therapeutics LLC

Cingulate Therapeutics LLC

Cingulate Therapeutics LLC

Overview
Date Founded

2012

Headquarters

1901 West 47th Place,3rd floor,Kansas City, KS 66205

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Executives & Employees

Co-Founder

Chairman & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Board of Directors

Chairman & Chief Executive Officer at Cingulate Therapeutics LLC

Managing Partner, Laidlaw Venture Partners at Laidlaw & Company (UK) Ltd.

Founder at Chemwerth, Inc.

Former President at KCBN Holding, Inc.

Chairman & Co-Founder at Embody, Inc.

Co-Founder at Cingulate Therapeutics LLC

Paths to Cingulate Therapeutics LLC
Potential Connections via
Relationship Science
You
Cingulate Therapeutics LLC
Recent Transactions
Details Hidden

Cingulate Therapeutics LLC raised money in a private placement transaction

Details Hidden

Cingulate Therapeutics LLC raised money in a private placement transaction

Advisors & Consultants
Publicist

Vice President at Tiberend Strategic Advisors, Inc.

Publicist

Professional at Tiberend Strategic Advisors, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cingulate Therapeutics LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cingulate Therapeutics LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Cingulate Therapeutics LLC.